The difference in Igf1-expressing myeloid cells in G-Smo and M-Smo tumors demonstrates an effect of tumor genotype on the TME that may feedback on tumor phenotype by altering tumor mTORC1 activation, and thus contribute to differences in tumor growth and recurrence. The gene discussed is IGF1; the disease is neoplasm.